Winrevair Disease Interactions
There are 2 disease interactions with Winrevair (sotatercept).
Sotatercept (applies to Winrevair) bleeding
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Thrombocytopenia
Sotatercept may cause severe thrombocytopenia and increase the risk of bleeding. Do not initiate treatment with sotatercept in patients with platelet counts below 50,000/mm3. Do not administer sotatercept in patients who are experiencing serious bleeding.
Sotatercept (applies to Winrevair) hepatic impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
The effect of hepatic impairment on the pharmacokinetics of sotatercept has not been studied.
Switch to professional interaction data
Winrevair drug interactions
There are 3 drug interactions with Winrevair (sotatercept).
Report options
More about Winrevair (sotatercept)
- Winrevair consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: agents for pulmonary hypertension
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
